Omino is led by a team of life science entrepreneurs with extensive experience in inflammation and tissue remodeling, partnerships and drug discovery collaborations.

Ulrika Norin. Chief executive officer

M.Sc. and PhD in Medicine.
Skilled project leader and scientist with more than 10 years research experience in inflammatory diseases and early drug discovery.

Lars Öhman. Director of the board.

Experienced business developer with a proven track record in drug discovery and business development within the pharmaceutical industry with over 25 years in wide-ranging research and businesses

Stefan K Nilsson. Board member

PhD in medicine.
Life science entrepreneur with a broad life science industry network. Co-founder and CEO of Nasdaq First North listed Lipigon Pharmaceuticals.

Tor Ny. Founder and Head of research and development.

Senior Professor at Umeå university and world-renowned researcher on plasminogen and its role in tissue remodeling including inflammation and wound healing. Founder of Umeå Biotech Incubator.